Reasonable value for what we paid. Bounce rate stayed under 4% on a 1,000-contact email send. Bought it to scope a Taiwan territory in the pathology lab segment. Acceptable trade-off at this price.
Good to know what worked and what didn't, we're actively working on the gaps you called out. If you want the gaps fixed sooner than the next refresh, open a support ticket and we'll spin a one-off pull.